Fumagillin
Fumagillin | |
---|---|
[[File:|frameless|220px|alt=|]] | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | 23110-15-8 |
PubChem | 5284447 |
DrugBank | DB04838 |
ChemSpider | 4445360 |
KEGG | D04197 |
Fumagillin is a natural product originally isolated from the fungus Aspergillus fumigatus. It is a complex organic compound that has been studied for its potential antimicrobial and antiparasitic properties. Fumagillin is particularly noted for its activity against microsporidia, a group of spore-forming unicellular parasites that can cause disease in immunocompromised individuals.
Mechanism of Action[edit | edit source]
Fumagillin exerts its effects by inhibiting the enzyme methionine aminopeptidase 2 (MetAP2). This inhibition disrupts the protein synthesis in microsporidia, leading to their death. The specific targeting of MetAP2 makes fumagillin a valuable tool in the treatment of microsporidial infections.
Medical Uses[edit | edit source]
Fumagillin has been used in the treatment of microsporidiosis, particularly in patients with HIV/AIDS who are more susceptible to these infections. It has also been explored for its potential use in treating intestinal microsporidiosis and other related conditions.
Side Effects[edit | edit source]
The use of fumagillin can be associated with several side effects, including gastrointestinal disturbances, hepatotoxicity, and bone marrow suppression. Patients receiving fumagillin should be monitored for these adverse effects, especially if they are on long-term therapy.
Research and Development[edit | edit source]
Research is ongoing to develop fumagillin analogs with improved efficacy and reduced toxicity. These efforts aim to enhance the therapeutic potential of fumagillin while minimizing its side effects.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Drug groups | Encyclopedia | Dictionary | Cancer drugs | OTC | Alternative meds | Drugs | Medications A-Z | FDA approved products | Portal:Pharmacology
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD